Clinical Trial

Analysis of Facial Expressions for Pain Recognition in Fibromyalgia: Using Artificial Intelligence and Biomarkers

Study acronym: Fibromyalgia
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated November 19, 2025 (before its estimated February 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
Fibromyalgia (FM) is a chronic musculoskeletal pain syndrome with characteristics of generalized body pain, low pain threshold, tenderness and stiffness in muscles, tendons and joints. The assessment of pain in this condition is a challenge due to its subjective nature. A promising approach to assessing pain intensity is facial expression analysis, which can serve as an objective indicator. In addition, research seeks to identify molecular molecular markers to quantify pain. However, the lack of a standardized system has made it difficult to identify reliable markers. In summary, the search for objective methods of assessing pain in fibromyalgia is essential in order to develop more effective more effective treatments. Facial expression analysis and the investigation of molecular markers are promising ways of quantifying pain intensity more accurately and intensity of pain more accurately and reliably in fibromyalgia.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-02-03.
Status change: Not Yet Recruiting → Recruiting 2025-11-17
Trial Details
NCT Number NCT06813352
Lead Sponsor Faculdade de Ciências Médicas de Minas Gerais
Collaborators: Fundação de Amparo à Pesquisa do estado de Minas Gerais, Conselho Nacional de Desenvolvimento Científico e Tecnológico
Conditions Fibromyalgia (FM), Pain, Catastrophizing Pain
Enrollment 122 participants
Start Date 2025-11-17
Primary Completion 2026-02-01 (estimated)
Study Completion 2026-09-01 (estimated)
Updated on ClinicalTrials.gov 2025-11-19